By Fineline Cube 
US-based Teleflex Incorporated (NYSE: TFX) announced that its Rüsch EZ-Blocker single-use bronchial blocker has received a medical device registration certificate from China’s National Medical Products Administration (NMPA). The product, registered under certificate number 20252080316, is designed for single-lung ventilation surgery. This approval introduces a new surgical option and broadens Teleflex’s product offerings in China.
Product Significance
Teleflex highlighted that this approval underscores its commitment to the Chinese market and its dedication to addressing patient needs. The company anticipates that this will drive business growth in China. Moving forward, Teleflex will continue to refine its product portfolio in China to support the advancement of the healthcare sector.-Fineline Info & Tech